سرطان الدم الحاد النخاعي في كبار السن (≥55 سنة) الذين لم يعودوا يتلقون العلاجات المضادة لسرطان الدم — رعاية نهاية الحياة والرعاية التلطيفية

References

DOI: 10.1182/bloodadvances.2025017934

For older adults with AML who are no longer receiving ALT (including those receiving end-of-life care or hospice care), the ASH guideline panel suggests having RBC transfusions be available over not having transfusions be available (conditional recommendation based on very low certainty in the evidence of effects ⨁◯◯◯).

There may be rare instances in which platelet transfusions may be of benefit in the event of bleeding, but there are even less data to support this practice and it is anticipated that platelet transfusions will have little or no role in end-of-life or hospice care.